4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-11-001443
PRES./CHIEF SCIENTIFIC OFFICER acquired 113,636 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-12-20 | Option exercise | +113,636 | $0.88 | $100,000 | 1,204,468 | D |
| Derivatives | |||||||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2011-12-20 | Option exercise · Stock Option (Right to Buy) | −113,636 | 0 | D | ||
Loading xslF345X03/form4-12222011_081210.xml…